GSK2220691
SK2220691 is a potent TRPV4 inhibitor. It effectively suppresses pulmonary edema induced by GSK1016790. Additionally, SK2220691 inhibits the increase of crucial factors such as VEGF, keratinocyte-derived chemokine (KC; CXCL1), and granulocyte colony-stimulating factor (GCSF) induced by hydrochloric acid.
Product Specifications
CAS Number
1206619-37-5
Field of Research
Pharmacology & Drug Discovery
Smiles
C ([C@@H] (NC (=O) C1=CC=2C (N1) =CC=CC2) [C@@] (C) (C) C) (=O) N3[C@@]4 (CN (C (=O) C5=CC=C (C=N5) C6=CC=CC=C6) [C@@] (C4) (C3) [H]) [H]
Molecular Formula
C32H33N5O3
Molecular Weight
535.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P1001-27L3-APC 200 µL
P53, phosphorylated (Thr18) (Cellular Tumor Antigen p53, Tumor Suppressor p53, Phosphoprotein p53, Antigen NY-CO-13, TP53, P53) (APC) discontinued
Sign In for Pricing
View Details 
MBS2121066-01 0.1 mL
Cy3-Linked Monoclonal Antibody to Lymphotoxin Beta Receptor (LTbR)
Sign In for Pricing
View Details MBS2121066-02 0.2 mL
Cy3-Linked Monoclonal Antibody to Lymphotoxin Beta Receptor (LTbR)
Sign In for Pricing
View Details MBS2121066-03 0.5 mL
Cy3-Linked Monoclonal Antibody to Lymphotoxin Beta Receptor (LTbR)
Sign In for Pricing
View Details